Summaries for patients. Using medication to prevent breast cancer: recommendations from the United States Preventive Services Task Force.

Abstract

Summaries for Patients2 July 2002Using Medication To Prevent Breast Cancer: Recommendations from the United States Preventive Services Task ForceSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-137-1-200207020-00005 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail What is the United States Preventive Services Task Force?The United States Preventive Services Task Force (USPSTF) is a group of physicians and other health care experts that reviews published research and makes recommendations about preventive health care.What is the problem and what is known about it so far?Breast cancer is a common type of cancer among women in the United States. Despite improvements in early detection and treatment, about 39,600 American women will die of breast cancer in 2002. Chemoprevention is a strategy for reducing the risk for cancer (“prevention”) by taking drugs (“chemo”). The drug tamoxifen ... Author, Article, and Disclosure InformationAffiliations: The summary below is from the full reports titled “Chemoprevention of Breast Cancer: Recommendations and Rationale” and “Chemoprevention of Breast Cancer: A Summary of the Evidence for the U.S. Preventive Services Task Force.” They are in the 2 July 2002 issue of Annals of Internal Medicine (volume 137, pages 56-58 and pages 59-67). The first report was written by the U.S. Preventive Services Task Force; the second report was written by LS Kinsinger, R Harris, SH Woolf, HC Sox, and KN Lohr.Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians-American Society of Internal Medicine. Previousarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoChemoprevention of Breast Cancer: Recommendations and RationaleChemoprevention of Breast Cancer: A Summary of the Evidence for the U.S. Preventive Services Task Force Linda S. Kinsinger , Russell Harris , Steven H. Woolf , Harold C. Sox , and Kathleen N. Lohr Metrics Cited byTamoxifen-associated vasculitis in a breast cancer patientPeut-on prévenir chimiquement le cancer du sein en 2003 ? 2 July 2002Volume 137, Issue 1Page: I-62KeywordsBreast cancerCancer preventionChemopreventionDrugsHealth careMedical risk factorsPreventive medicineStrokeThrombosisUterus ePublished: 2 July 2002 Issue Published: 2 July 2002 Copyright & PermissionsCopyright © 2002 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...